Apomorphine Subcutaneous and Ranibizumab Intraocular
Determining the interaction of Apomorphine Subcutaneous and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: apomorphine
Brand name: Apokyn, APO-Go, APO-Go Pen, Uprima
Synonyms: Apomorphine
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Apomorphine Subcutaneous-Ranibizumab ophthalmic
- Apomorphine Subcutaneous-Ranitidine
- Apomorphine Subcutaneous-Ranitidine Capsule
- Apomorphine Subcutaneous-Ranitidine Hydrochloride
- Apomorphine Subcutaneous-Ranitidine Injection
- Apomorphine Subcutaneous-Ranitidine Suspension
- Ranibizumab Intraocular-Apra
- Ranibizumab Intraocular-Apraclonidine
- Ranibizumab Intraocular-Apraclonidine Hydrochloride
- Ranibizumab Intraocular-Apraclonidine ophthalmic
- Ranibizumab Intraocular-Apremilast
- Ranibizumab Intraocular-Aprepitant